TCRT
TCRT
NASDAQ · Biotechnology

Alaunos Therapeutics Inc

$2.82
-0.16 (-5.37%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +1,355.0% upside
Low Target $36.60
Average Target $41.03
High Target $68.97
Current Price $2.82
Current
$2.82
Target
$41.03
$36.60 $41.03 avg $68.97
Scenario Analysis
Bear Case
$36.60
1,197.9%
Low target
Base Case
$41.03
+1,355.0%
Avg target
Bull Case
$68.97
+2,345.7%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$6.20
-54.5% from high
52-Week Low
$1.31
+114.7% from low
Target vs 52W High
$41.03
+561.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +18.4%
AMGN
Amgen Inc
Hold 42 50% $190.87 -45.8%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +160.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -1.8%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -69.1%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -12.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -28.5%